DHCP communication on azacitidine 25 mg / ml powder for suspension for injection
Important information on drugs containing irinotecan (active ingredient: irinotecan hydrochloride 3 H2O): drug toxicity in patients with reduced UGT1A1 activity
Hamburg / Dassow, December 21, 2021
Informing healthcare professionals about drug toxicity in patients with decreased UGT1A1 activity.
You can find the file here.
AqVida GmbH Premium Oncology ProductsQuality - Made in Germany
We are available for current company topics and interview requests:
Saskia Heinze
Claudia Schubert
Phone: 49 (0) 40 / 380 371 9 - 0
Mail: pr@aqvida.com
Hamburg / Dassow, May 20th, 2021
Informing healthcare professionals about the potential risk of incorrect reconstitution (medication errors).
You can find the file here.
AqVida GmbH Premium Oncology ProductsQuality - Made in Germany
We are available for current company topics and interview requests:
Saskia Heinze
Claudia Schubert
Phone: 49 (0) 40 / 380 371 9 - 0
Mail: pr@aqvida.com